SupportLoginSign Up
Featured FeedJournalsCollectionsKeywords
JOURNAL ARTICLE
PRACTICE GUIDELINE
Add like
Add dislike
Add to saved papers

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Hugh Calkins, Karl Heinz Kuck, Riccardo Cappato, Josep Brugada, A John Camm, Shih-Ann Chen, Harry J G Crijns, Ralph J Damiano, D Wyn Davies, John DiMarco, James Edgerton, Kenneth Ellenbogen, Michael D Ezekowitz, David E Haines, Michel Haissaguerre, Gerhard Hindricks, Yoshito Iesaka, Warren Jackman, José Jalife, Pierre Jais, Jonathan Kalman, David Keane, Young-Hoon Kim, Paulus Kirchhof, George Klein, Hans Kottkamp, Koichiro Kumagai, Bruce D Lindsay, Moussa Mansour, Francis E Marchlinski, Patrick M McCarthy, J Lluis Mont, Fred Morady, Koonlawee Nademanee, Hiroshi Nakagawa, Andrea Natale, Stanley Nattel, Douglas L Packer, Carlo Pappone, Eric Prystowsky, Antonio Raviele, Vivek Reddy, Jeremy N Ruskin, Richard J Shemin, Hsuan-Ming Tsao, David Wilber
Heart Rhythm : the Official Journal of the Heart Rhythm Society 2012 April
No abstract text is available yet for this article.

Full text links

Find Full Text Links for this Article

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Do Not Sell My Personal InformationManage Cookie Preferences

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app